Press Releases

Emmaus Life Sciences Receives FDA Approval for Endari® Label Enhancements

Jun 26, 2025 9:30am EDT

Emmaus Life Sciences Reports Quarterly Financial Results

May 15, 2025 4:30pm EDT

Emmaus Life Sciences Reports 2024 Financial Results

Apr 14, 2025 6:25pm EDT

Emmaus Life Science Reports Grant of Endari Market Exclusivity In Kingdom of Saudi Arabia

Jan 29, 2025 9:30am EST

Emmaus Life Sciences Reports Improved Quarterly Financial Results

Nov 19, 2024 5:00pm EST

Emmaus Life Sciences Reports Quarterly Financial Results

Sep 10, 2024 2:15pm EDT

Emmaus Life Sciences Announces Willis C. Lee as Chief Executive Officer

Jul 23, 2024 10:00am EDT

Emmaus Life Sciences Announces Outcome of FDA Inspection of Postmarketing Adverse Drug Experience Compliance Program

Jul 12, 2024 10:00am EDT

Emmaus Life Sciences Reports 2023 Financial Results

Jul 03, 2024 9:00am EDT

Emmaus Life Sciences Reports Delayed Filing of Annual Report

Apr 15, 2024 4:07pm EDT